Depression and Anxiety Trial, Recruiting NCT05680220 Sponsor: Klaus Martiny Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT05680220
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 75 years old
  • People who have been diagnosed with major depressive disorder and are currently going through a depressive episode, as defined by the DSM-5 (a standard medical guideline for mental health conditions)
  • People whose depression symptoms score above 21 on the MDI (Major Depression Inventory), a standard rating scale, at the time of screening
  • People who have been on a stable treatment plan — such as medication and/or talking therapy — for at least 4 weeks before the trial begins
  • People who are willing and able to use the trial device for 1 hour per day over 6 weeks, following the scheduled plan
  • People who can understand spoken and written information about the study and are willing to sign a consent form

Who may not be able to join:

  • People with a history of migraines triggered by light (photosensitive migraines) or epileptic seizures
  • People with a known eye condition that may be sensitive to light-based treatment
  • People with a known diagnosis of bipolar disorder, as defined by DSM-5 criteria
  • People with thoughts of suicide at a level of 2 or higher on a standard clinical scale (HAM-D item 3), or where there is any uncertainty about the level of risk from the patient or the doctor
  • People who are currently experiencing psychotic symptoms (note: people who have had psychotic depression in the past, or whose psychotic symptoms have since resolved, may still be considered — confirm with trial site)
  • People with a current drug or alcohol dependency, based on medical records or a clinical interview
  • People with a known history of borderline personality disorder
  • People who are currently taking part in another clinical treatment trial
  • People with a progressive neurological condition or a cancer-related illness
  • People who are unable to understand the study procedures or how to use the trial device
  • People who are pregnant at the time of joining the trial, or women of childbearing age who are not using reliable contraception

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Klaus Martiny, Senior Consultant at Psychiatric Centre Copenhagen

Phone: +45 38 64 71 00

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Klaus Martiny
Registry
ClinicalTrials.gov
Start date
5 October 2023
Est. completion
30 June 2027

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Depression severity measured by Hamilton Depression Rating sub-scale (HAM-D6)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov